Clinical Trials Logo
  1. Home
  2. Familial Mediterranean Fever
  3. NCT06257342
  4. Details
NCT06257342 Clinical Trial

Physical Abilities of Teenagers With Familial Mediterranean Fever

Familial Mediterranean Fever Clinical Trial

— Sport & FMF  

Official title:
Physical Abilities of Teenagers With Familial Mediterranean Fever

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT06257342
Other study ID # P23/04
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 30, 2023
Est. completion date December 31, 2027

Study information
Verified date June 2023
Source Versailles Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Physical abilities of teenagers with familial Mediterranean fever

Description:

Physical abilities of teenagers with familial Mediterranean fever by describing the maximum oxygen consumption (VO2max) estimated from a 6-minute walk test

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 10
Est. completion date December 31, 2027
Est. primary completion date October 15, 2027
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: - Patients with a clinical diagnosis of FMF according to the Tel-Hashomer criteria for whom a sports evaluation was offered during their bridging program - Age >12 - Followed or having been followed in the pediatric department of the CH of Versailles - No opposition of the patient and his/her parent/legal guardian in case of a minor patient Exclusion Criteria: Expressed refusal of the patient and his/her parent/legal guardian to participate in the study and/or to use genetic data for research purposes

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• 6 minutes walk
A 6 minutes walk test

Locations
Country Name City State
France CH de Versailles Le Chesnay

Sponsors (1)
Lead Sponsor Collaborator
Véronique Hentgen

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary the maximum oxygen consumption (VO2max) estimated from the 6-minute walk test Describe the maximum oxygen consumption (VO2max) estimated from the 6-minute walk test 6 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT00658060 - Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients N/A
Withdrawn NCT05448391 - A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) Phase 2
Recruiting NCT05190991 - Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever Phase 2
Completed NCT00094900 - Interleukin-1 Trap to Treat Autoinflammatory Diseases Phase 2
Not yet recruiting NCT06033339 - Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology N/A
Completed NCT01705756 - Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever Phase 3
Recruiting NCT06338891 - Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
Recruiting NCT05596643 - Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever
Enrolling by invitation NCT02175589 - Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation Phase 2
Completed NCT05177120 - Central Sensitization in Familial Mediterranean Fever (FMF)
Recruiting NCT04478409 - Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
Recruiting NCT06034795 - Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever
Completed NCT04729218 - The Movement Imagery Ability in Patients With Familial Mediterranean Fever
Terminated NCT01059279 - Heat Intolerance in the Group of FMF Patients
Enrolling by invitation NCT04724993 - Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever N/A
Completed NCT03747315 - A Diagnostic Test for Familial Mediterranean Fever
Completed NCT01075906 - Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients Phase 1
Completed NCT00582907 - Rilonacept for Treatment of Familial Mediterranean Fever (FMF) Phase 2
Withdrawn NCT00323440 - Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission N/A
Not yet recruiting NCT05488561 - Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings N/A